GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » PB Ratio

GeneTether Therapeutics (XCNQ:GTTX) PB Ratio : 0.94 (As of May. 16, 2024)


View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-16), GeneTether Therapeutics's share price is C$0.045. GeneTether Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was C$0.05. Hence, GeneTether Therapeutics's PB Ratio of today is 0.94.

The historical rank and industry rank for GeneTether Therapeutics's PB Ratio or its related term are showing as below:

XCNQ:GTTX' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 100
Current: 0.94

During the past 4 years, GeneTether Therapeutics's highest PB Ratio was 100.00. The lowest was 0.00. And the median was 0.00.

XCNQ:GTTX's PB Ratio is ranked better than
82.6% of 1322 companies
in the Biotechnology industry
Industry Median: 2.54 vs XCNQ:GTTX: 0.94

During the past 12 months, GeneTether Therapeutics's average Book Value Per Share Growth Rate was -7.70% per year.

Back to Basics: PB Ratio


GeneTether Therapeutics PB Ratio Historical Data

The historical data trend for GeneTether Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics PB Ratio Chart

GeneTether Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PB Ratio
- - 1.92 0.83

GeneTether Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 1.11 0.71 0.90 0.83

Competitive Comparison of GeneTether Therapeutics's PB Ratio

For the Biotechnology subindustry, GeneTether Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GeneTether Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneTether Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where GeneTether Therapeutics's PB Ratio falls into.



GeneTether Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

GeneTether Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.045/0.048
=0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


GeneTether Therapeutics  (XCNQ:GTTX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


GeneTether Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneTether Therapeutics (XCNQ:GTTX) Business Description

Traded in Other Exchanges
N/A
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines